The platform technology approach to mRNA product development and regulation
Tracks
Track 1
| Thursday, October 31, 2024 |
| 11:50 AM - 12:35 PM |
| Plenary Room |
Details
mRNA technology is transforming the way humankind develops and delivers medicines. Now we must reimagine our approach to the way mRNA products are assessed and regulated in order to deliver their potential to people in urgent need. Australia has the opportunity to lead the world in the way it safely evaluates new mRNA medicines and Australian industry, government and academia are working together to drive change that optimises the potential of mRNA science.
Speaker
Dr Amanda Caples
Lead Scientist, Victoria
Department of Jobs, Skills, Industry & Regions - Victorian Government
Chair
Prof Terry Nolan
Redmond Barry Distinguished Professor Emeritus
Doherty Institute
Panellist
Prof. John Skerritt AM
Enterprise Professor in Health Research Impact
The University of Melbourne
Panellist
Prof. Brett Sutton
Director Health And Biosecurity
CSIRO
Panellist
Dr Carolyn Tucek-Szabo
Senior Director: Global Regulatory Sciences Lead - Aust Policy & Liaison - SE Asiaralia/NZ
Moderna
Panellist
